Skip to main content
Clinical Trials/NCT06381999
NCT06381999
Completed
N/A

Initial Assessment of the Validity and Inter-Rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool

Merz Therapeutics GmbH1 site in 1 country73 target enrollmentOctober 27, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Post-stroke Spasticity
Sponsor
Merz Therapeutics GmbH
Enrollment
73
Locations
1
Primary Endpoint
Assessment of the level of agreement between the nurse group and gold-standard group (trained, specialized physicians) in their decision for toxin treatment referral
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to investigate the validity and Inter-rater reliability for early recognition of spasticity by nurses and physiotherapists using the decision tree tool.

Detailed Description

The Spastic Movement Disorder (SMD) Decision Tree was designed as a tool to aid nurses, therapists and other healthcare professions recognize potential signs of disabling spasticity in the upper limb of post-stroke patients. The present study assesses validity and inter-rater reliability of the SMD Decision Tree comparing nurses and therapists with gold-standard procedure performed by rehabilitation doctors. Agreement was tested for "referral to specialist indicated" and "no referral to specialist indicated".

Registry
clinicaltrials.gov
Start Date
October 27, 2023
End Date
February 26, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participants with a first sub-acute and chronic infarction of the middle cerebral artery / basal ganglia hemorrhage longer than four weeks after the event
  • Between 18-80 years old
  • Preserved insight and judgment capacity
  • Adequate language and task comprehension, attention span for 15 minutes

Exclusion Criteria

  • Participants with other neurological disorders
  • Participants who received BoNT-A treatment \< 3 months before inclusion
  • Reduced vigilance and attention span (less than 15 minutes)
  • Participants with adult representation
  • Participants with severe language impairment / impairment of movement and action sequences

Outcomes

Primary Outcomes

Assessment of the level of agreement between the nurse group and gold-standard group (trained, specialized physicians) in their decision for toxin treatment referral

Time Frame: Day 1-2

Nurses use the 3 domains of the SMD Decision Tree (passive/active movement, pain) to determine potential disabling spasticity indicated for referral to a rehabilitation specialist. Specialized physicians use standard clinical procedure to detect disabling spasticity.

Secondary Outcomes

  • Assessment of the level of agreement between the physiotherapist and/or occupational therapist group and gold-standard group (trained, specialized physicians) in their decision for toxin treatment referral(Day 1-2)

Study Sites (1)

Loading locations...

Similar Trials